Corporate Partners
The Crohn's & Colitis Foundation is proud to recognize the support of our sponsors from around the world. We thank these companies for joining with us in the battle against inflammatory bowel disease. We are always open to new sponsor support from all types of organizations. Interested in partnering with the Foundation? Contact us today!

Our approach
Our philosophy is to create robust, strategic and successful opportunities in tandem with our corporate partners—we focus on developing a strong relationship beyond one event or promotion.

Corporate support
We're grateful for the generous support of our national corporate partners. The Foundation thanks each of these companies for supporting us in our mission to find cures for IBD!

Pathways to partnership
There are variety of meaningful ways to partner with the Foundation. Browse opportunities including cause marketing, event sponsorship, programmatic partnership, workplace giving and more.

Shop and support
You can support the Crohn's & Colitis Foundation's work by shopping with our partners! A portion of proceeds will directly benefit programs, services and critical research.
Thank you to our partners!

Our partners made an impact in 2019
Our work would not be possible without the support of our partners. To date, we have raised more than $16m in corporate partnerships. That means more than $16m towards research, education, support and advocacy programs to help find cures and improve the lives of those affected by Crohn's or colitis.
Join us in the fight against IBD
Crohn's & Colitis Foundation
The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn’s disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.